Multiple myeloma is a cancer of plasma cells that weakens bones, disrupts normal blood cell production, and can compress critical structures such as the spinal cord. While systemic therapies remain the foundation of treatment, Multiple Myeloma Surgery plays an important supportive role in managing skeletal complications, relieving pain, and preserving function.
Key Takeaways
- Surgery for multiple myeloma is not a curative treatment but is used to address structural complications such as fractures and spinal cord compression.
- The most common multiple myeloma surgical treatment options include kyphoplasty, vertebroplasty, internal fixation, and decompressive spinal surgery.
- Spinal surgery is most urgent when cord compression threatens neurological function, requiring prompt intervention.
- Minimally invasive procedures like kyphoplasty can restore vertebral height and significantly reduce pain.
- Surgical decisions are always made within the context of a broader oncology treatment plan involving radiation, chemotherapy, and targeted therapy.
When Is Multiple Myeloma Surgery Recommended?
Surgery is not a primary treatment for multiple myeloma because the disease is systemic rather than localized to a single tumor. Medical management with chemotherapy, immunotherapy, and targeted agents remains central to controlling the cancer itself. However, surgery for multiple myeloma becomes necessary when the disease causes structural damage that cannot be adequately addressed through medications or radiation alone.
The most common indications include pathological fractures of the long bones or vertebrae, impending fracture in a significantly weakened bone, and spinal cord or nerve root compression. According to the International Myeloma Foundation, approximately 80% of patients with multiple myeloma develop bone disease during the course of their illness, making skeletal complications the leading reason surgical consultation is sought. Pain that is refractory to conservative measures may also prompt surgical evaluation, particularly when imaging confirms structural instability.
Physicians assess several factors before recommending an operation, including the patient’s overall performance status, current disease burden, bone marrow function, and expected response to systemic therapy. Patients with a pathological fracture of a weight-bearing bone — such as the femur — typically require surgical stabilization regardless of their systemic treatment status, because fracture healing in myeloma bone is unreliable without mechanical support. The decision is individualized and made collaboratively by oncologists, orthopedic surgeons, and neurosurgeons.
Types of Multiple Myeloma Surgery: Bone, Fracture, and Spinal Procedures
Multiple myeloma surgical treatment options span a spectrum from minimally invasive cement augmentation techniques to open orthopedic and neurosurgical procedures. The appropriate choice depends on the location and severity of bone involvement, the degree of neurological compromise, and the patient’s overall health status.
Multiple myeloma bone surgery and fracture repair typically involves internal fixation using intramedullary nails, plates, or prosthetic joint replacement when a long bone such as the humerus or femur is fractured or at imminent risk. Unlike fractures in healthy bone, myeloma-related fractures heal poorly because the surrounding bone marrow is infiltrated by malignant plasma cells. Prophylactic fixation — stabilizing a bone before it breaks — is often preferred when imaging shows more than 50% cortical destruction in a weight-bearing bone, as it reduces the risk of a complete fracture and shortens recovery time.
The types of surgery used in multiple myeloma treatment also extend to the spine, where vertebral involvement is extremely common. Decompressive laminectomy, a procedure that removes part of the vertebral arch to relieve pressure on the spinal cord or nerve roots, is performed when neurological deficits are present or worsening. In some cases, spinal fusion is added to restore mechanical stability after decompression. Radiation therapy is often administered before or after spinal surgery to reduce the local tumor burden and limit the risk of recurrence at the operative site.
| Procedure | Target Area | Primary Goal | Typical Setting |
|---|---|---|---|
| Intramedullary nailing / plate fixation | Long bones (femur, humerus) | Fracture stabilization | Orthopedic surgery |
| Prosthetic joint replacement | Hip, shoulder | Restore mobility after severe bone loss | Orthopedic surgery |
| Kyphoplasty | Vertebral body | Height restoration and pain relief | Interventional/neurosurgery |
| Vertebroplasty | Vertebral body | Stabilization and pain relief | Interventional radiology |
| Laminectomy ± spinal fusion | Spinal canal | Cord decompression and stability | Neurosurgery |
Kyphoplasty and Vertebroplasty in Multiple Myeloma Treatment
Kyphoplasty and vertebroplasty for multiple myeloma are minimally invasive procedures designed to stabilize collapsed or fractured vertebrae using bone cement, most commonly polymethylmethacrylate (PMMA). Both techniques are performed through small skin incisions and guided by fluoroscopic or CT imaging, allowing surgeons to target the affected vertebra with precision while minimizing surgical trauma.
Vertebroplasty involves injecting bone cement directly into the fractured vertebral body to stabilize it and relieve pain. Kyphoplasty adds an initial step: a small balloon is inserted and inflated within the collapsed vertebra to restore some of its original height before the cement is injected into the cavity created. This distinction is clinically meaningful. Kyphoplasty can partially reverse vertebral collapse and may reduce the risk of cement leakage compared with vertebroplasty, though both procedures have demonstrated significant analgesic benefit in patients with painful myeloma-related compression fractures.
Clinical evidence supports the use of these procedures in appropriately selected patients. Studies published in peer-reviewed oncology journals report that 70–90% of patients experience meaningful pain reduction following kyphoplasty or vertebroplasty, with improved mobility and reduced reliance on opioid analgesics. The procedures are generally well tolerated even in patients with compromised bone marrow function, though careful patient selection and imaging review are essential to minimize the risk of cement extravasation into the spinal canal. Radiation therapy is commonly used in combination with these procedures to address the underlying tumor.
Patient Selection Criteria for Cement Augmentation
Not every patient with a vertebral compression fracture is a candidate for kyphoplasty or vertebroplasty. Surgeons evaluate the degree of vertebral collapse, the integrity of the posterior vertebral wall, the presence of epidural tumor extension, and the patient’s current systemic therapy plan. Patients with severe posterior wall disruption or significant spinal cord compression from tumor tissue may require open decompressive surgery instead of, or in addition to, cement augmentation.
Combining Cement Augmentation with Radiation Therapy
Radiation therapy directed at the involved vertebra is frequently administered alongside or shortly after vertebral augmentation procedures. The cement stabilizes the bone mechanically, while radiation reduces the local tumor burden and limits disease progression at that site. This combined approach has become standard practice in many comprehensive myeloma centers, offering durable pain relief and structural support within a multimodal treatment framework.
Multiple Myeloma Surgery Outcomes and Role in Overall Care
Surgical outcomes in multiple myeloma depend heavily on the timing of intervention, the extent of bone disease, and the effectiveness of concurrent systemic therapy. When performed for appropriate indications, surgery can meaningfully improve quality of life by reducing pain, restoring mobility, and preventing catastrophic neurological injury. Multiple myeloma spinal surgery for cord compression is particularly time-sensitive: early intervention — ideally within 24 to 48 hours of symptom onset — is associated with significantly better rates of neurological recovery compared with delayed surgery.
Longer-term outcomes are influenced by disease response to systemic treatment. Patients who achieve deep remission following chemotherapy or immunotherapy tend to experience fewer recurrent skeletal complications and may not require additional surgical procedures. Conversely, patients with relapsed or refractory disease may face progressive bone involvement that necessitates repeat interventions. Bone-strengthening agents such as bisphosphonates or denosumab are routinely prescribed alongside surgical treatment to slow bone resorption and reduce the incidence of future skeletal-related events.
Surgery in multiple myeloma is never curative and must be viewed as one component of a comprehensive, multidisciplinary care plan. Coordination between hematologic oncologists, orthopedic surgeons, neurosurgeons, radiation oncologists, and palliative care specialists ensures that surgical decisions align with the patient’s overall treatment goals, functional priorities, and disease trajectory. Shared decision-making with the patient and family is essential, particularly when weighing the benefits of an operation against potential risks in the context of an already complex systemic illness.
Frequently Asked Questions
Can surgery cure multiple myeloma?
Surgery cannot cure multiple myeloma because the disease originates in the bone marrow and is systemic by nature. Surgical procedures address specific complications — such as fractures or spinal cord compression — but do not eliminate the underlying malignant plasma cells. Curative intent in myeloma is pursued through systemic therapies, including chemotherapy, targeted agents, and stem cell transplantation, often used in combination over the course of treatment.
Is kyphoplasty safe for patients undergoing chemotherapy?
Kyphoplasty is generally considered safe for myeloma patients receiving systemic chemotherapy, though timing and blood count status must be carefully evaluated beforehand. Adequate platelet levels and the absence of active infection are typically required before proceeding. The procedure is minimally invasive and associated with a low complication rate. Oncologists and surgeons collaborate to schedule the procedure at a point in the treatment cycle that minimizes bleeding and infection risk.
How quickly does spinal surgery need to happen for cord compression?
Spinal cord compression in multiple myeloma is a medical emergency. Decompressive surgery is most effective when performed within 24 to 48 hours of symptom onset, such as new weakness, numbness, or loss of bladder or bowel control. Delays beyond this window significantly reduce the likelihood of neurological recovery. High-dose corticosteroids are typically administered immediately upon diagnosis to reduce swelling while surgical and radiation options are rapidly evaluated.
